Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Users Online: 493 | Home Print this page Email this page Small font size Default font size Increase font size
Year : 2002  |  Volume : 22  |  Issue : 2  |  Page : 42-48

Immunomodulating effects of rasayana drugs in diabetics- A clinical study

1 Department of Pharmacology, Universal College of Medical Sciences, Bhairahawa, Nepal
2 Department of Dravyaguna, I.M.S.B.H.U., Varanasi, India
3 Department of Immunopthology I.M.S., BH.U., Varanasi, India

Correspondence Address:
Deepa Arora
Department of Pharmacology, Universal College of Medical Sciences, Bhairahawa
Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

Immune system plays an important role in pathogenesis of diabetes (DM). Besides hypoglycaemics, rasayanas are indicated in the management of DM. In several studies the immunomodulatroy potentials of rasayanas have been proved. A clinical trial of three rasayana drugs, Asparagus recemosus (AR). Bacopa monnieri (BM) and Centella asiatica (CA) was carried out in diabetics. In this study, diabetics were found to have significantly lower levels of serum IgG, increased serum IgA and comparable levels of IgM. All drugs reverted levels of serum IgG levels in diabetics, however, statistical significance was attained only with AR. Further the increased IgA levels were brought back towards normal. These drugs also increased serum protein levels.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded87    
    Comments [Add]    

Recommend this journal